is tirzepatide off the shortage list FDA reconsidering its decision to take its drug Mounjaro and Zepbound no longer

GLP-1 receptor agonists (semaglutide, dulaglutide, liraglutide) work by enhancing insulin secretion, suppressing glucagon, slowing gastric emptying, and reducing appetite

This is worth being aware of, particularly during the early weeks when you are still learning how your body responds

These are not isolated incidents - for some, bowel issues become a predictable part of their weekly injection cycle

Our healthcare professionals will closely monitor your progress and make adjustments as needed to ensure safety and effectiveness

Message with your care team and schedule follow-ups

Consulting with healthcare providers will ensure that the chosen medication aligns well with lifestyle and therapeutic goals.